![Todd E. Golde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Todd E. Golde
No más puestos en curso
Perfil
Todd E.
Golde is the founder of Lacerta Therapeutics, Inc. which was founded in 2017.
Antiguos cargos conocidos de Todd E. Golde.
Empresas | Cargo | Fin |
---|---|---|
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Todd E. Golde